Abstract
Recent advances in our understanding of GPCR pharmacology have caused a paradigm shift in our perception of GPCR signaling. Intracellular signaling of receptors, formation of non-canonical effector complexes, β-arrestin's actions as a signal transducer, and the ability for multiple proteins to occupy the intracellular sites of the receptor simultaneously are all now widely accepted concepts. Despite this, our knowledge of Orexin Receptor 2 (OX2R) pharmacology has remained largely unchanged. In this study, OX2R pharmacology was investigated using various BRET techniques with a focus on spatio-temporal mechanisms. Upon stimulation with Orexin-A (OX-A) or Orexin-B (OX-B), dissociation and/or rearrangement of Gq, Gi and Gs with distinct, ligand-dependent kinetic effects was observed. Robust trafficking of Gi, but not Gq to intracellular compartments was observed with both ligands, however only Gi dissociation in response to OX-B exhibited resistance to extracellular agonist washout. Gαi and β-arrestin2 came into closer proximity following agonist stimulation. Together, these findings indicate a series of complex signaling mechanisms that can be ligand-dependent, G protein-dependent or both. This warrants further research to determine the physiological relevance of OX2R spatio-temporal pharmacology.
| Original language | English |
|---|---|
| Article number | 117517 |
| Number of pages | 15 |
| Journal | Biochemical Pharmacology |
| Volume | 243 |
| Issue number | Part 2 |
| DOIs | |
| Publication status | Published - Jan 2026 |
Funding
| Funders | Funder number |
|---|---|
| NHMRC National Health and Medical Research Council | 1085842 |
| ARC Australian Research Council | LP160100857, IC170100016 |
Fingerprint
Dive into the research topics of 'Orexin receptor 2 (OX2R) exhibits ligand-dependent spatio-temporal pharmacology through Gαi:β-arrestin dynamics in response to Orexin-A and Orexin-B'. Together they form a unique fingerprint.Projects
- 3 Finished
-
ARC Training Centre for Personalised Therapeutics Technologies
Stewart, A. (Investigator 01), Pfleger, K. (Investigator 02), Voelcker, N. (Investigator 03), Pebay, A. (Investigator 04), Dottori, M. (Investigator 05), Lee, P. (Investigator 06), Elnathan, R. (Investigator 07), O'Connor, A. (Investigator 08), Rodger, J. (Investigator 09), Doyle, B. (Investigator 10), Kennedy, B. (Investigator 11), Heng, J. (Investigator 12), Sercombe, T. (Investigator 13), Zheng, M. (Investigator 14) & Volery, T. (Investigator 15)
1/01/18 → 31/12/22
Project: Research
-
Development of technologies to monitor multimolecular complexes
Pfleger, K. (Investigator 01), Rosengren, K. (Investigator 02), Hill, S. (Investigator 03), Abbenante, G. (Investigator 04), Wood, K. (Investigator 05) & Williams, J. (Investigator 06)
ARC Australian Research Council
1/01/16 → 2/11/19
Project: Research
-
The molecular pharmacology of receptor complexes
Pfleger, K. (Investigator 01)
NHMRC National Health and Medical Research Council
1/01/15 → 31/12/18
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver